Literature DB >> 12551720

Strain-dependent modification of behavior following antidepressant treatment.

Shanaz Tejani-Butt1, Joseph Kluczynski, William P Paré.   

Abstract

The effects of repeated antidepressant drug treatment on behavioral outcome in Wistar Kyoto (WKY) rats, a putative animal model of depressive behavior, were compared to Wistar and Sprague-Dawley (SD) rats. Rats were treated with desipramine (norepinephrine [NE] uptake blocker), nomifensine (NE and dopamine [DA] uptake blocker), paroxetine (serotonin [5-HT] uptake blocker) or saline, for 12 days. On Day 11, rats were tested in the Porsolt forced swim test (FST). On Day 12, rats were tested in the open field test (OFT). Stress reactivity was assessed on Day 13 when all rats were exposed to water-restraint ulcerogenic stress. Significant strain differences in behavioral responses to the drug treatments were observed. Control WKY rats showed the typical freezing behavior in the OFT and excessive floating behavior in the FST as compared to Wistar and SD rats. Desipramine and nomifensine decreased immobility and increased swim time in the FST in WKY rats. Nomifensine reduced response latency in the OFT in WKY rats and increased activity in the OFT in WKY and SD rats. None of the drugs altered the FST in SD rats. Following ulcerogenic stress, desipramine was the only antidepressant that decreased ulcer incidence in all rat strains compared to saline controls. These results suggest that the "depressive behavior" in WKY rats may be modified by antidepressants that alter synaptic levels of NE and/or DA, but not 5-HT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551720     DOI: 10.1016/s0278-5846(02)00308-1

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  50 in total

1.  Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF.

Authors:  Sheketha R Hauser; Bruk Getachew; Robert E Taylor; Yousef Tizabi
Journal:  Pharmacol Biochem Behav       Date:  2011-09-10       Impact factor: 3.533

2.  Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF.

Authors:  Laura L Hurley; Luli Akinfiresoye; Evaristus Nwulia; Atsushi Kamiya; Amol A Kulkarni; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2012-11-08       Impact factor: 3.332

3.  Estrogen effects on the forced swim test differ in two outbred rat strains.

Authors:  Wendy A Koss; Haim Einat; Robert J Schloesser; Husseini K Manji; David R Rubinow
Journal:  Physiol Behav       Date:  2012-01-12

4.  Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling.

Authors:  Shuichi Chiba; Tadahiro Numakawa; Midori Ninomiya; Hyung Shin Yoon; Hiroshi Kunugi
Journal:  Psychopharmacology (Berl)       Date:  2010-06-05       Impact factor: 4.530

5.  Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine.

Authors:  Laurent Naudon; Maïté Hotte; Thérèse M Jay
Journal:  Psychopharmacology (Berl)       Date:  2007-01-12       Impact factor: 4.530

6.  Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression.

Authors:  Bruk Getachew; Liliana Mendieta; Antonei B Csoka; José Aguilera; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2019-05-22       Impact factor: 3.332

7.  Changes in behavior and ultrasonic vocalizations during antidepressant treatment in the maternally separated Wistar-Kyoto rat model of depression.

Authors:  P J van Zyl; J J Dimatelis; V A Russell
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

8.  Differential patterns of alcohol consumption and dopamine-2 receptor binding in Wistar-Kyoto and Wistar rats.

Authors:  Irene Morganstern; Shanaz Tejani-Butt
Journal:  Neurochem Res       Date:  2010-08-03       Impact factor: 3.996

9.  Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study.

Authors:  O Malkesman; T Asaf; L Shbiro; A Goldstein; R Maayan; A Weizman; N Kinor; E Okun; B Sredni; G Yadid; A Weller
Journal:  Adv Pharmacol Sci       Date:  2009-10-18

10.  Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

Authors:  Gregory V Carr; Debra A Bangasser; Thelma Bethea; Matthew Young; Rita J Valentino; Irwin Lucki
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.